Preeclampsia Diagnosis Using β‐Hairpin Peptide for ELABELA Detection
Journal of Peptide Science · 2026-05 · 32 (5)
DOI: 10.1002/psc.70095 ↗At a glance
Journal article in Journal of Peptide Science, published online on 2026-03-27. Written by Behafarid Ghalandari and 7 co-authors. Institution: Department of Anesthesiology and Surgical Intensive Care Unit, Xinhua Hospital, School of Medicine and School of Biomedical Engineering, Shanghai Jia…. Major MEDLINE topics: Peptide Hormones, Pre-Eclampsia, Peptides. 34 references. Funded by: National Key R&D Program of China, NSFC, Shanghai Municipal Science and Technology Project.
Abstract (original language)
Preeclampsia (PE) poses risks to mothers and infants, especially in low‐resource settings. Diagnosis of PE is difficult due to nonspecific symptoms and limited biomarker screening. ELABELA, a circulating peptide hormone and endogenous ligand of the apelin receptor (APJ), has emerged as a promising biomarker for earlier detection of PE, alone or in combination with other biomarkers. Here, we present β‐hairpin protein epitope mimetics (BH‐PEMs) as a tool for ELABELA detection. Employing an epitope mimetics approach, OP27 from a BH‐PEM peptide library emerged as a high‐affinity candidate for ELABELA following rational design and screening of a focused peptide library. Experimental assays verified the OP27‐ELABELA complex's stability and binding affinity. We successfully detected ELABELA in clinical donor serum samples using the OP27‐ELABELA complex–based electrochemical method integrated with electrochemical impedance spectroscopy (EIS), enabling sensitive detection in a complex biological matrix. Our findings establish a proof‐of‐concept biomarker‐driven electrochemical detection strategy for PE, supporting the development of simplified electrochemical diagnostic approaches while highlighting the broader applicability of BH‐PEM probes in biomarker detection. The BH‐PEM probe demonstrates feasibility for biomarker‐driven PE detection and warrants further validation in expanded clinical cohorts, thereby contributing to improved maternal risk assessment and mitigation of health risks for mothers and infants.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Anesthesiology and Surgical Intensive Care Unit, Xinhua Hospital, School of Medicine and School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China.
- State Key Laboratory of Systems Medicine for Cancer, Institute for Personalized Medicine, Shanghai Jiao Tong University, Shanghai, China.
- Department of Surgical Biotechnology, Division of Surgery and Interventional Science, University College London, London, UK.
- Institute of Orthopaedic & Musculoskeletal Science, University College London, Royal National Orthopaedic Hospital, Stanmore, UK.
ORCID profiles: Lai Jiang, Xianting Ding
Funding
- National Key R&D Program of China
- NSFC
- Shanghai Municipal Science and Technology Project
- Shanghai Municipal Education Commission Project
- Shanghai Jiao Tong University Projects
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Cite
APA
Ghalandari, B., Jessica, J., Zhang, Q., Azmat, M., Ghorbani, F., Su, W., Jiang, L., & Ding, X. (2026). Preeclampsia Diagnosis Using β‐Hairpin Peptide for ELABELA Detection. Journal of Peptide Science, 32(5). https://doi.org/10.1002/psc.70095
Vancouver
Ghalandari B, Jessica J, Zhang Q, Azmat M, Ghorbani F, Su W, et al. Preeclampsia Diagnosis Using β‐Hairpin Peptide for ELABELA Detection. Journal of Peptide Science. 2026;32(5). doi:10.1002/psc.70095
BibTeX
@article{Ghalandari2026,
author = {Ghalandari, Behafarid and Jessica, Jessica and Zhang, Qiang and Azmat, Mehmoona and Ghorbani, Farnaz and Su, Wenqiong and Jiang, Lai and Ding, Xianting},
title = {Preeclampsia Diagnosis Using β‐Hairpin Peptide for ELABELA Detection},
journal = {Journal of Peptide Science},
year = {2026},
volume = {32},
number = {5},
doi = {10.1002/psc.70095}
}
EUVIMED